Navigation Links
Statement on Comparative Effectiveness Research Under Senate Appropriations Committee Stimulus Bill
Date:1/27/2009

Language a Step Forward for Patient-Provider Decision Making

Further Action Needed to Ensure Research Reflects America

WASHINGTON, Jan. 27 /PRNewswire-USNewswire/ -- "The Senate today improved on a comparative effectiveness research (CER) package from the House by focusing the $1.1 billion dollar research effort on clinical effectiveness," said Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the nation's leading Hispanic health advocacy group. She added, "The Senate Appropriations Committee has rejected House report language that put cost over quality and was a prescription for bad health.

"House stimulus package language had urged that those treatments found 'more expensive, will no longer be prescribed.' The Senate instead calls for the CER program to focus specifically on clinical effectiveness. The Senate language recognizes that a decision on the best treatment for an individual patient must be made between the patient and their provider, not a federal research or rulemaking body.

"While the Senate language is an improvement , it is important that further steps be taken to ensure that research and governance reflect those that the research seeks to serve."

According to Dr. Delgado two outstanding issues are critical.

1. Final legislation must specifically enforce current policies for inclusion in research. House language was silent on inclusion of gender, race, ethnicity, and disability. While the Senate improves on House language, the final legislation should specifically call for research to be in compliance with the federal Agency for Healthcare Research and Quality Policy on the Inclusion of Priority Populations in Research.

2. Governance must be changed from an all federal board to include majority governance by patient and provider groups. Current House language calls for a 15 person governance board of only federal officials to oversee the $1.1 billion CER program. An all federal panel will not reflect the real-life concerns of patients and providers and inevitably lead to science and spending that does not meet the needs of patients for better quality care.

"We appreciate the work of the Senate Appropriations and Finance Committees and in particular thank Senators Baucus, Conrad, Harkin, and Inouye for their leadership on improving the CER program under the stimulus package. We look forward to our work with the Senate and House in the days ahead to develop a package that puts patients and quality first."

About the National Alliance for Hispanic Health

The National Alliance for Hispanic Health is the nation's foremost source of information and trusted advocate for the health of Hispanics in the United States. The Alliance represents thousands of Hispanic health providers across the nation providing services to more than 15 million each year, making a daily difference in the lives of Hispanic communities and families. For more information, visit http://www.hispanichealth.org or call the Alliance's Su Familia National Hispanic Family Health Helpline at 1-866-783-2645.


'/>"/>
SOURCE National Alliance for Hispanic Health
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Psychoanalysts Approve Position Statement on Homosexuals and Bisexuals Serving in the Military
2. American Life League Statement on Pelosis State-Enforced War on Preborn Babies
3. Statement on Presidential Memorandum to EPA to Review Lifting of Ban on California Clean Car Standard
4. Endocare Announces Filing of Form S-4 Registration Statement Related to Proposed Merger With Galil Medical
5. Pelosi Statement on Obama Executive Order Repealing Global Gag Rule
6. Catholics for Choice Statement on Overturning the Mexico City Policy
7. UHW Statement on Ray Marshall Trusteeship Recommendations
8. Pelosi Statement on the 36th Anniversary of Roe v. Wade
9. Statement by UHW on SEIUs Claims Regarding SEIU-Trusteeship Hearing Process Chaired by Ray Marshall
10. Capital Blue Cross Issues Statement on Withdrawal of Merger
11. The LCA-Vision Full Value Committee Files Preliminary Consent Solicitation Statement to Reconstitute the Board of Directors of LCA-Vision Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... 2016 , ... The law firm of Morrow, Morrow, Ryan & Bassett is ... these scholarships is to encourage applicants to pursue a degree in their field of ... parishes. , “We have available jobs in St. Landry and Evangeline Parishes that ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... As a ... hectic schedule, a demanding job, and no time to decompress, Rabinowitz found herself drawn ... herself to meditation for its impact on her life, implementing a 20-minute-per-day meditation practice ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... at Zuckerberg San Francisco General Hospital on April 5-7. The series is a ... create new habits. The workshops cover a broad range of topics, including coaching ...
(Date:2/12/2016)... ... , ... Fisher House Foundation Chairman and CEO Kenneth Fisher joined Governor Brian ... president Scott Bensing, and Peggy Kearns Director, VA Southern Nevada Healthcare System yesterday to ... will be the first Fisher House in Nevada, and will provide free lodging for ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... 2016  Sequent Medical, Inc. announced today that it ... the safety and effectiveness of the WEB™ Aneurysm Embolization ... aneurysms.  Prof Laurent Spelle , MD, Head of ... France and Principal Investigator of the CLARYS ... and Germany.  Although patients with ruptured aneurysms ...
(Date:2/12/2016)... and SEOUL, South Korea ... Biosys­tems Menarini and Macrogen, Inc. today announced they ... and innovative procedures for precision medicine in cancer. ... Silicon Biosystems, DEPArray™ digital-sorting technology with Macrogen,s high-throughput ... tests certified under the Clinical Laboratory Improvement Amendments ...
(Date:2/12/2016)... MILTON, Ontario , Feb. 12, 2016  Aralez ... specialty pharmaceutical company, today announced the Company will ring the ... Square, New York at 4:00 ... the formation of Aralez. Adrian Adams ... will be held 3:50 to 4:00 p.m. ET.  A ...
Breaking Medicine Technology: